Editas Medicine Inc. (EDIT)
NASDAQ · Healthcare
Editas Medicine Inc. Revenue 2016–2025
Editas Medicine Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Editas Medicine Inc. revenue for the quarter ending March 31, 2026 was 2.8 M, a 39.22% decrease year-over-year.
- Editas Medicine Inc. revenue for the twelve months ending March 31, 2026 was 18.6 M, a 164.16% increase year-over-year.
- Editas Medicine Inc. annual revenue for 2025 was 40.5 M, a 25.39% increase from 2024.
- Editas Medicine Inc. annual revenue for 2024 was 32.3 M, a 58.64% decrease from 2023.
- Editas Medicine Inc. annual revenue for 2023 was 78.1 M, a 296.32% increase from 2022.
- Editas Medicine Inc. annual revenue for 2022 was 19.7 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Editas Medicine Inc. Earnings — FAQ
Editas Medicine Inc. (EDIT) earnings over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EDIT's earnings history?
The chart and table above show Editas Medicine Inc.'s earnings by year and by quarter, including the growth rate.